Latest Neurodegeneration Stories
-Discovery of Novel Investigational Drug Candidates that Interact with sigma-2/PGRMC1 Receptor Offer Potential to Stop and Reverse Memory Loss in Alzheimer's Patients - PITTSBURGH,
Informational lunch seminar educates those living with neurodegenerative diseases and caregivers about advancements in Parkinson's and Alzheimer's research GRAND RAPIDS, Mich., Nov.
Dr. Hefti to Lead All Clinical Development Efforts and Strategic Initiatives CAMBRIDGE, Mass., Nov.
Scientists have described a way to convert human skin cells directly into a specific type of brain cell affected by Huntington’s disease, an ultimately fatal neurodegenerative disorder.
Alice Lazzarini, PhD, and internationally recognized researcher in neurogenetic disorders, announces the donation of a portion of proceeds
New White Paper also Available on Disease that is a Leading Cause of Young-Onset Dementia RADNOR, Pa., Aug.
No longer just fantastical fodder for sci-fi buffs, cyborg technology is bringing us tangible progress toward real-life electronic skin, prosthetics and ultraflexible circuits. Now taking this human-machine concept to an unprecedented level.
An experimental anti-inflammatory drug can protect vulnerable neurons and reduce motor deficits in a rat model of Parkinson’s disease.
Researchers at the UNC School of Medicine have discovered that the protein PARC/CUL9 helps neurons and brain cancer cells override the biochemical mechanisms that lead to cell death in most other cells.
WASHINGTON, June 29, 2014 /PRNewswire-USNewswire/ -- In work supported by The ALS Association, researchers have shown that increasing the clearance of misfolded protein from neurons improves
- A woman chauffeur.
- A woman who operates an automobile.